89 related articles for article (PubMed ID: 36849307)
1. Distinctive Attributes of Indian Patients With Classical BCR::ABL1 Negative Myeloproliferative Neoplasms: Unified Clinical and Laboratory Data.
Singh S; Singh J; Mehta A; Sharma R; Joshi K; Jain K; Paul D; Oberoi G; Jindal N; Dhillon B; Narang V
Clin Lymphoma Myeloma Leuk; 2023 May; 23(5):360-369.e1. PubMed ID: 36849307
[TBL] [Abstract][Full Text] [Related]
2. JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms.
Giraldo-Rincón AI; Naranjo Molina S; Gomez-Lopera N; Aguirre Acevedo D; Ucroz Benavidez A; Gálvez Cárdenas K; Cuellar Ambrosí F; Torres JD; Ospina S; Palacio K; Gaviria Jaramillo L; Muñeton CM; Vasquez Palacio G
Colomb Med (Cali); 2023; 54(3):e2035353. PubMed ID: 38111518
[TBL] [Abstract][Full Text] [Related]
3. Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors.
Helbig G
Med Oncol; 2018 Aug; 35(9):119. PubMed ID: 30074114
[TBL] [Abstract][Full Text] [Related]
4. Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
Tefferi A; Vannucchi AM; Barbui T
Am J Hematol; 2024 Apr; 99(4):697-718. PubMed ID: 38269572
[TBL] [Abstract][Full Text] [Related]
5. Broad Next-Generation Integrated Sequencing of Myelofibrosis Identifies Disease-Specific and Age-Related Genomic Alterations.
Kandarpa M; Robinson D; Wu YM; Qin T; Pettit K; Li Q; Luker G; Sartor M; Chinnaiyan A; Talpaz M
Clin Cancer Res; 2024 May; 30(9):1972-1983. PubMed ID: 38386293
[TBL] [Abstract][Full Text] [Related]
6. A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients.
Zaidi U; Sufaida G; Rashid M; Kaleem B; Maqsood S; Mukry SN; Khan RZA; Munzir S; Borhany M; Shamsi TS
BMC Cancer; 2020 Mar; 20(1):205. PubMed ID: 32164591
[TBL] [Abstract][Full Text] [Related]
7. The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis: Current perspective.
Pescia C; Lopez G; Cattaneo D; Bucelli C; Gianelli U; Iurlo A
Leuk Res; 2024 Jan; 136():107420. PubMed ID: 38016412
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and genetic characteristics of young patients with myeloproliferative neoplasms].
Zhang MY; Bao M; Shi DY; Shi HX; Liu XL; Xu N; Duan MH; Zhuang JL; Du X; Qin L; Hui WH; Liang R; Wang MF; Chen Y; Li DY; Yang W; Tang GS; Zhang WH; Kuang X; Su W; Han YQ; Chen LM; Xu JH; Liu ZG; Huang J; Zhao CT; Tong HY; Hu JD; Chen CY; Chen XQ; Xiao ZJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2023 Mar; 44(3):193-201. PubMed ID: 37356980
[No Abstract] [Full Text] [Related]
9.
Mroczkowska-Bękarciak A; Wróbel T
Front Genet; 2023; 14():1241912. PubMed ID: 37745842
[TBL] [Abstract][Full Text] [Related]
10. Classification and Personalized Prognosis in Myeloproliferative Neoplasms.
Grinfeld J; Nangalia J; Baxter EJ; Wedge DC; Angelopoulos N; Cantrill R; Godfrey AL; Papaemmanuil E; Gundem G; MacLean C; Cook J; O'Neil L; O'Meara S; Teague JW; Butler AP; Massie CE; Williams N; Nice FL; Andersen CL; Hasselbalch HC; Guglielmelli P; McMullin MF; Vannucchi AM; Harrison CN; Gerstung M; Green AR; Campbell PJ
N Engl J Med; 2018 Oct; 379(15):1416-1430. PubMed ID: 30304655
[TBL] [Abstract][Full Text] [Related]
11. Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study.
England JT; Szuber N; Sirhan S; Dunne T; Cerquozzi S; Hill M; Villeneuve PJA; Ho JM; Sadikovic B; Bhai P; Krishnan N; Dowhanik S; Hillis C; Capo-Chichi JM; Tsui H; Cheung V; Gauthier K; Sibai H; Davidson MB; Bankar A; Kotchetkov R; Gupta V; Maze D
Leukemia; 2024 Mar; 38(3):570-578. PubMed ID: 38321107
[TBL] [Abstract][Full Text] [Related]
12. Chronic myeloproliferative neoplasms with concomitant
Zanelli M; Fragliasso V; Loscocco GG; Sanguedolce F; Broggi G; Zizzo M; Palicelli A; Ricci S; Ambrogi E; Martino G; Aversa S; Coppa F; Gentile P; Gozzi F; Caltabiano R; Koufopoulos N; Asaturova A; Cimino L; Cavazza A; Orcioni GF; Ascani S
Front Cell Dev Biol; 2024; 12():1391078. PubMed ID: 38596359
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinicopathological features of driver gene mutations profile in BCR: ABL1 negative classical myeloproliferative neoplasm-A single-center study from North India.
Rahman K; Biswas S; Sharma A; Gupta K; Chandra D; Singh MK; Gupta R; Mishra A; Kumar S; Gupta A; Hasan F; Nityanand S; Kahsyap R
Indian J Pathol Microbiol; 2024 Mar; ():. PubMed ID: 38718214
[TBL] [Abstract][Full Text] [Related]
14. Long-acting interferon: pioneering disease modification of myeloproliferative neoplasms.
Yoon SY; Kim SY
Korean J Intern Med; 2023 Nov; 38(6):810-817. PubMed ID: 37939664
[TBL] [Abstract][Full Text] [Related]
15. Co-occurrence of
Zanelli M; Bisagni A; Sanguedolce F; Broggi G; Fragliasso V; Zizzo M; Palicelli A; Martino G; Cresta C; Caprera C; Corsi M; Gentile P; Gozzi F; Trombetta D; Parente P; Caltabiano R; Koufopoulos N; Cimino L; Cavazza A; Fraternali Orcioni G; Ascani S
Front Oncol; 2023; 13():1329298. PubMed ID: 38282677
[TBL] [Abstract][Full Text] [Related]
16. In utero origin of myelofibrosis presenting in adult monozygotic twins.
Sousos N; Ní Leathlobhair M; Simoglou Karali C; Louka E; Bienz N; Royston D; Clark SA; Hamblin A; Howard K; Mathews V; George B; Roy A; Psaila B; Wedge DC; Mead AJ
Nat Med; 2022 Jun; 28(6):1207-1211. PubMed ID: 35637336
[TBL] [Abstract][Full Text] [Related]
17. The evolving treatment paradigm in myelofibrosis.
Mesa RA
Leuk Lymphoma; 2013 Feb; 54(2):242-51. PubMed ID: 22793267
[TBL] [Abstract][Full Text] [Related]
18. Extensive Hepatic Infarction due to Polycythemia Vera.
Furukawa K; Urano F; Okamura S; Kawashima H
J Gastrointestin Liver Dis; 2024 Mar; 33(1):18. PubMed ID: 38554424
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis- and Prognosis-Related Gene Alterations in
Morishita S; Komatsu N
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629188
[No Abstract] [Full Text] [Related]
20. [Primary myelofibrosis with double mutation in U2AF1].
Maeyama K; Nagaharu K; Ino K; Sugimoto Y; Tawara I; Kawakami K
Rinsho Ketsueki; 2024; 65(1):30-34. PubMed ID: 38311386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
